HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hye Suk Lee Selected Research

KR-31612

10/2002Simultaneous determination of the novel neuroprotective agent KR-31378 and its metabolite KR-31612 using high performance liquid chromatography with tandem mass spectrometry in human plasma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hye Suk Lee Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 02/2011
7Reperfusion Injury
04/2007 - 10/2002
6Carcinogenesis
01/2022 - 11/2015
5Inflammation (Inflammations)
11/2021 - 01/2018
5Breast Neoplasms (Breast Cancer)
10/2020 - 07/2014
4Colonic Neoplasms (Colon Cancer)
12/2021 - 01/2013
4Infections
11/2021 - 01/2012
4Asthma (Bronchial Asthma)
04/2017 - 08/2009
4Ischemia
02/2004 - 10/2002
3Body Weight (Weight, Body)
11/2021 - 06/2011
3Gout
02/2021 - 01/2018
3Melanoma (Melanoma, Malignant)
01/2020 - 12/2012
3Skin Neoplasms (Skin Cancer)
01/2020 - 12/2012
3Lung Neoplasms (Lung Cancer)
01/2019 - 02/2014
2Poisoning
04/2022 - 07/2018
2Porcine Reproductive and Respiratory Syndrome (PRRS)
11/2021 - 01/2020
2Obesity
11/2021 - 01/2021
2Arthritis (Polyarthritis)
02/2021 - 01/2018
2Mitochondrial Diseases (Mitochondrial Disease)
02/2021 - 01/2020
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 06/2014
2Rheumatoid Arthritis
09/2020 - 01/2018
2Acne Vulgaris
09/2020 - 12/2018
2Neoplastic Cell Transformation
10/2015 - 02/2014
2Peripheral Nervous System Diseases (PNS Diseases)
07/2014 - 01/2013
2Diabetic Neuropathies (Diabetic Neuropathy)
07/2014 - 01/2013
1Skin Diseases (Skin Disease)
11/2021
1Atopic Dermatitis (Atopic Eczema)
11/2021
1Dermatitis
11/2021
1Retinoblastoma (Glioblastoma, Retinal)
02/2021
1Acute Coronary Syndrome
02/2021
1Atrial Fibrillation
02/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Disease Progression
01/2021

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2012
9InflammasomesIBA
02/2021 - 01/2018
9Pharmaceutical PreparationsIBA
09/2020 - 08/2009
4Epidermal Growth Factor (EGF)IBA
02/2021 - 12/2012
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2020 - 07/2014
4Organic Anion TransportersIBA
10/2020 - 07/2014
4AnionsIBA
10/2020 - 07/2014
4Peptides (Polypeptides)IBA
10/2020 - 07/2014
4AgarIBA
04/2019 - 12/2012
4Neuroprotective AgentsIBA
02/2004 - 10/2002
3Mitogen-Activated Protein KinasesIBA
01/2022 - 02/2014
3Uric Acid (Urate)IBA
02/2021 - 01/2018
3CytochromesIBA
10/2020 - 10/2003
3CationsIBA
10/2020 - 07/2014
3AntioxidantsIBA
10/2018 - 04/2017
3Guanidine (Guanidine Nitrate)FDA Link
04/2007 - 11/2005
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 03/2020
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
12/2021 - 04/2019
2kaempferolIBA
12/2021 - 01/2018
2Pattern Recognition ReceptorsIBA
11/2021 - 01/2020
2celastrolIBA
11/2021 - 01/2019
2CytokinesIBA
11/2021 - 01/2019
2LignansIBA
02/2021 - 12/2014
2Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
09/2020 - 02/2015
2EnzymesIBA
09/2020 - 02/2015
2Glutathione (Reduced Glutathione)IBA
01/2020 - 07/2017
2Adenosine Triphosphate (ATP)IBA
01/2020 - 01/2019
2NLR ProteinsIBA
06/2019 - 01/2018
2TOR Serine-Threonine KinasesIBA
01/2019 - 10/2015
2Phosphotransferases (Kinase)IBA
01/2019 - 10/2015
2magnolinIBA
01/2019 - 02/2014
2Pyrin Domain-Containing 3 Protein NLR FamilyIBA
01/2019 - 12/2018
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
07/2017 - 02/2015
2verprosideIBA
04/2017 - 09/2009
2DA-9801IBA
07/2014 - 01/2013
2(5- (2- methoxy- 5- chloro- 5- phenyl)furan- 2- ylcarbonyl)guanidineIBA
04/2007 - 01/2006
2Cardiotonic Agents (Cardiac Stimulants)IBA
04/2007 - 11/2005
2furanIBA
04/2007 - 01/2006
2KR-31543IBA
02/2004 - 10/2002
2BenzopyransIBA
02/2004 - 10/2002
2N''- cyano- N- (6- amino- 3,4- dihydro- 3- hydroxy- 2- methyl- 2- dimethoxymethyl- 2H- benzopyran- 4- yl)- N'- benzylguanidineIBA
10/2003 - 10/2002
1amatoxinIBA
04/2022
1Mitogen-Activated Protein Kinase 6IBA
01/2022
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2021
1Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2021
1AllergensIBA
11/2021
1Thymic Stromal LymphopoietinIBA
11/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
11/2021
1Interleukin-13IBA
11/2021
1Interleukin-4 (Interleukin 4)IBA
11/2021
1IFIH1 Interferon-Induced HelicaseIBA
11/2021
1Interleukin-5 (Interleukin 5)IBA
11/2021
1fargesinIBA
02/2021
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
02/2021
1CyclinsIBA
02/2021
1Cyclin EIBA
02/2021
1Cyclin-Dependent Kinase 2IBA
02/2021
1loganinIBA
02/2021
1Interleukin-18 (Interleukin 18)IBA
02/2021
1DronedaroneFDA Link
02/2021
1TicagrelorIBA
02/2021
1methylamphotericin B (AME)IBA
01/2021
1Phosphatidylcholines (Phosphatidylcholine)IBA
01/2021
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2021
1ProteomeIBA
01/2021

Therapy/Procedure

7Therapeutics
03/2020 - 01/2012
4Oral Administration
02/2021 - 01/2018